Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksREDX.L Share News (REDX)

  • There is currently no data for REDX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: Stocks Start Mostly Lower Amid Profit Taking

Tue, 31st Dec 2019 08:51

(Alliance News) - London stocks were lower on Tuesday morning, with some traders remaining away from their desks ahead of the New Year's Day holiday, while others were cashing out of a flagging Santa Rally.

The FTSE 100 index was down 43.63 points, or 0.6%, at 7,543.42 early Tuesday. The mid-cap FTSE 250 index was 33.44 points lower, or 0.2%, at 21,902.82, and the AIM All-Share index was flat at 958.11.

The retreat follows a strong Christmas week for London shares, with the FTSE 250 index of mid-caps reaching a record closing high, breaching the 22,000 mark for the first time.

The Cboe UK 100 index was down 0.6% at 12,783.36. The Cboe 250 was 0.2% lower at 19,815.78, and the Cboe Small Companies flat at 12,247.11.

The London Stock Exchange will close early at 1230 GMT for New Year's Eve. It will re-open on Thursday for a full session.

Sterling was quoted at USD1.3130 early Tuesday, flat with USD1.3136 at the London equities close on Monday.

In other currencies, the euro was trading at USD1.1205 early Tuesday, soft on USD1.1216 late Monday. Against the yen, the dollar was at JPY108.63, down slightly from JPY108.83.

In mainland Europe, the CAC 40 in Paris was down 0.4%. Financial markets in France will close early on Tuesday, while German markets are completely closed for New Year's Eve. Italy and Switzerland also are closed all day.

In Asia on Tuesday, financial markets were closed in Japan. In China, the Shanghai Composite ended up 0.3%, while the Hang Seng index in Hong Kong closed down 0.5%.

Tokyo will remain shut until Monday, while the Shanghai and Hong Kong markets are closed on New Year's Day but reopen on Thursday.

Back in London, HSBC Holdings started the day 0.6% lower after the Financial Times reported that the bank is planning to expand its exchange traded fund range in 2020 in order to revitalise its underperforming asset management business.

Nicholas Moreau, who was appointed chief executive of HSBC's asset management division in August, has devised a series of initiatives aimed at reinvigorating growth at a time when the London-listed bank is aggressively cutting costs, the FT said.

In the first half of 2020, HSBC will launch eight ETF's employing environmental, social and governance metrics to tap into rising investor demand for ESG-focused strategies.

HSBC also plans to develop a fixed income ETF platform in 2020 and to launch a range of precious metals tracker funds later in the year, the FT noted.

On AIM, Redx Pharma surged 31% in early trade to 8.68 pence. The company reported it is in "active" discussions with Samuel Waksal and associates, which could lead to a possible cash offer for the company.

In the meantime, the drug discovery and development company called on its shareholders to vote in favour of the conversion of a GBP2.5 million loan into shares. A general meeting will be held on January 21.

"We believe that this short-term funding solution will allow us time to secure the necessary longer-term funding that will enable us to advance our innovative pipeline of novel precision medicines for cancer and fibrosis," explained Chair Iain Ross.

The loan agreement was signed back in June with Moulton Goodies Ltd, Redx's largest shareholder which has over 18% stake, for a fixed rate secured loan note facility of up to GBP2.5 million. The loan is repayable in full on Tuesday. However, Moulton has requested that Redx capitalise the whole of the loan, including all unpaid interest, into new shares.

The capitalisation price pursuant to the terms of the loan notes is 5.25p per share, which will result in the issue of 52.0 million new shares to Moulton.

In the red early Tuesday was KCR Residential REIT, down 9.3%, after saying that it has been unable to publish its results for the year to the end of June until the end of 2019. The company explained that it is in the process of finalising the audit and the results will be announced "as soon as possible".

The delay is procedural having been caused by time-delays during the course of the audit which started later than expected following the closing of the corporate transaction with Torchlight Fund, the company said.

KCR Residential REIT shares will be suspended on Thursday.

Gold was quoted at USD1,524.30 early Tuesday, up from USD1,515.03 at the London equities close on Monday.

Brent oil was trading at USD66.48 early Tuesday, firm on USD66.14 at the London equities close on Monday.

The economic events calendar on Tuesday has only US data. The Johnson Redbook retail sales index is at 1355 GMT, with the monthly house price index at 1400 GMT and the US consumer confidence index at 1500 GMT.

By Evelina Grecenko; evelinagrecenko@alliancenews.com

Copyright 2019 Alliance News Limited. All Rights Reserved.

More News
5 Nov 2018 12:52

Redx Pharma Showcases Positive Preclinical Trial Results Of RXC004

LONDON (Alliance News) - Redx Pharma PLC on Monday reported a positive data from preclinical studies evaluating RXC004.The results were presented at the National Cancer Research Institute a

Read more
29 Oct 2018 14:50

Redx CEO Lisa Anson elected to Bioindustry Association board

(Sharecast News) - Drug development company Redx Pharma noted an announcement from the UK BioIndustry Association (BIA) on Monday that Lisa Anson had been elected to serve on the BIA board of directors.

Read more
24 Apr 2018 11:17

Redx Pharma Hires AstraZeneca UK President As Chief Executive

LONDON (Alliance News) - Shares jumped in Redx Pharma PLC on Tuesday as it announced the appointment of AstraZeneca PLC executive Lisa Anson as chief executive officer with effect on June in the I

Read more
22 Mar 2018 13:43

Redx Pharma Signs Agreement For Anti-Infective Programme With Deinove

LONDON (Alliance News) - Drug development company Redx Pharma PLC said Thursday that it has signed an option and licence agreement with chemicals company Deinove SAS for Novel

Read more
9 Feb 2017 14:21

RedX Pharma as it proposes discounted capital raising

(ShareCast News) - Shares in RedX Pharma are down almost 5% as it proposes raising £12m, before expenses, via a placing and subscription to advance its drugs pipeline. The proposed placing was of up to 20.5m shares, while the subscription was of 11.5m shares by Lanstead Capital, an institutional inv

Read more
30 Nov 2016 10:13

Redx Pharma To Present Pre-Clinical Profile Of RXC004 At Conference

Read more
20 Oct 2016 11:34

Redx Pharma identifies candidate for inhibitor programme

(ShareCast News) - Drug-development company Redx Pharma has identified a candidate for its reversible Bruton's tyrosine kinase (BTK) inhibitor programme. The compound, named RXC005, has the potential to treat the majority of patients suffering from chronic lymphocytic leukaemia (CLL), including tho

Read more
20 Oct 2016 08:33

Redx Pharma Selects Drug Candidate To Treat Leukaemia

Read more
27 Sep 2016 09:33

WINNERS & LOSERS SUMMARY: Wolseley Sold Amid Job Cuts, No Extra Payout

Read more
19 Sep 2016 08:13

Redx Pharma Sees Cancer Immunotherapy Promise For Porcupine Inhibitor

Read more
11 Sep 2016 15:25

Sunday share tips: Dunelm Group, Green REIT, Redx Pharma

(ShareCast News) - Buy shares in Dunelm Group, said the Sunday Times' Inside the City column. On Wednesday the home furnishings retailer is due to publish its first annual results under new chief executive John Browett. In the final three months of the year the FSTE 250 company - a sort of cut-price

Read more
24 May 2016 09:33

Redx Pharma Loss Widens But Notes Oncology Lead Progress

Read more
19 May 2016 10:17

Redx Pharma Welcomes Paper On Tackling Antimicrobial Resistance

Read more
9 May 2016 07:46

Redx Pharma Appoints David Lawrence Non-Executive Director

Read more
24 Mar 2016 14:08

Redx Pharma Raising GBP10.0 Million To Progress Its Pipeline (ALLISS)

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.